fordham drugs inc

1564 east 174th street
bronx, new york 10472

NYS Entity Status
ACTIVE

NYS Filing Date
SEPTEMBER 03, 2013

NYS DOS ID#
4453665

County
BRONX

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - FORDHAM DRUGS INC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Insurers Battle Families Over Costly Drug for Fatal Disease
    By KATIE THOMAS - Thursday Jun 22, 2017

    The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

    Source: NYT > Home Page
  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
    By STEPHANIE CLIFFORD - Thursday Jun 22, 2017

    The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.

    Source: NYT > Home Page
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • The New War on (Overpriced) Drugs
    By David Ferry - Saturday Jun 10, 2017

    Drug prices are too high. Meet the man who could fix them and the surprising opponents who want him to go away.

    Source: Webmonkey
  • Draft Order on Drug Prices Proposes Easing Regulations
    By SHEILA KAPLAN and KATIE THOMAS - Tuesday Jun 20, 2017

    A draft of an executive order obtained by The Times appears to give the drug industry what it wants with no guarantee that consumer costs will fall.

    Source: NYT > Home Page